Breaking News

You are here » Indian-Commodity  :  Top News  :  Biocon gets EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim

01-Dec2017

Biocon gets EMA regulator nod for proposed biosimilar trastuzumab, pegfilgrastim

Mylan N.V. and Biocon announced that the European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Applicat- ions (MAA) for proposed biosimilar trastuzumab and proposed biosimilar pegfilgrastim. Trastuzumab is used to treat certain HER2-positive breast and gastric cancers. Pegfilgrastim is used to reduce the duration of neutropenia (low count of neutrophils, a type of white blood cells) and the incidence of fever associated with neutropenia in adult patients treated with chemotherapy in certain types of cancer.

EMA acceptance of the submissions follows an earlier withdrawal of both applications in response to an audit conducted by the European inspecting authority of Biocon's drug product facility. Biocon has completed the Corrective and Preventive Actions (CAPAs) outlined as a result of the audit observations. The CAPAs will be confirmed during re-inspection, which will be completed as part of the regulatory review process.

Good Manufacturing Practice (GMP) compliance certificates for Biocon's two drug substance manufacturing facilities in Bangalore have been issued previously. Approval of these sites is key in the development and approval process as drug substance manufacture is core to the production of the actual biologic product in GMP compliance.

Biocon is India's largest and Asia's leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Related News

View all news

Gold futures edge higher on Monday

Gold futures edged higher on Monday, despite a firm dollar followed by reports of better than expected economic growth of US. However, investments were almost muted after the long Easter weekend.Gold futures......

Physical rubber prices ruled steady on Saturday

Physical Rubber prices ruled steady on Saturday. Spot prices for RSS-4 and RSS-5 variety closed unchanged at Rs 128/ kg and Rs 125/ kg respectively.In the futures market, May delivery gained to Rs 129.89......

Jeera futures trade lower on easing demand

Jeera futures traded lower on NCDEX on account of easing demand from retailers and industrial buyers at the spot market. Further, ample stocks position following higher supplies from the producing belts......

Top News

View all news

Bank of Baroda's board to consider issuance of equity shares of Rs 5,042 crore to Govt

Bank of Baroda's board is going to consider issuance of equity shares of Rs 5,042 crore to Government of India on a Preferential Basis. The meeting of the Board of Directors of the Bank is scheduled to......

Gujarat Petrosynthese to invest surplus funds in mutual funds, bonds, securities, shares

Gujarat Petrosynthese has received an approval to invest surplus funds in mutual funds, bonds, securities, shares, inter corporate deposits etc. to optimize its returns. The Board of Directors of the Company......

Reliance's Retail Unit delivers record-breaking performance in revenue, profits during FY19

Reliance Industries' Retail Unit--Reliance Retail has delivered a record-breaking performance in revenue and profits growth for the year 2018-19. Segment Revenue for FY19 grew by 88.7% Y-o-Y to Rs 130,566......